KEGG   PATHWAY: nle05212
Entry
nle05212                    Pathway                                
Name
Pancreatic cancer - Nomascus leucogenys (northern white-cheeked gibbon)
Description
Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term 'pancreatic cancer' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signalling pathway.
Class
Human Diseases; Cancer: specific types
Pathway map
nle05212  Pancreatic cancer
nle05212

Organism
Nomascus leucogenys (northern white-cheeked gibbon) [GN:nle]
Gene
100593773  KRAS; GTPase KRas isoform X1 [KO:K07827]
100588218  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100580872  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100584384  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100605788  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100591270  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
100599301  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
100595322  ARHGEF6; rho guanine nucleotide exchange factor 6 isoform X3 [KO:K05729]
100604516  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100598232  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
100602123  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X3 [KO:K07861]
100581655  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
100588439  RELA; transcription factor p65 [KO:K04735]
100604331  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100587864  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100587109  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100596225  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
100588081  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
100603768  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
101178725  BAD; bcl2-associated agonist of cell death [KO:K02158]
100595330  BCL2L1; bcl-2-like protein 1 [KO:K04570]
100597173  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
100595311  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100582848  BRAF; serine/threonine-protein kinase B-raf isoform X2 [KO:K04365] [EC:2.7.11.1]
100582599  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100579506  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100600574  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100584480  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100581677  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
100605285  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
100602081  MAPK10; mitogen-activated protein kinase 10 isoform X2 [KO:K04440] [EC:2.7.11.24]
100589231  RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
100579487  LOW QUALITY PROTEIN: ral-GDS-related protein [KO:K08732]
115835869  LOW QUALITY PROTEIN: ral-GDS-related protein-like [KO:K08732]
100603441  RALA; ras-related protein Ral-A [KO:K07834]
100593053  RALB; ras-related protein Ral-B [KO:K07835]
100600679  RALBP1; ralA-binding protein 1 [KO:K08773]
100605245  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
100605600  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
100601695  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
100607585  TGFA; protransforming growth factor alpha isoform X3 [KO:K08774]
100588963  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
100597255  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
100601700  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
100594291  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
100606492  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
100593862  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
100588162  JAK1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
100598877  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
100596344  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
100601396  VEGFA; vascular endothelial growth factor A isoform X1 [KO:K05448]
100586796  CDKN2A; cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
100594967  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
100602542  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
100605736  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
100588629  RB1; retinoblastoma-associated protein [KO:K06618]
100601097  E2F1; transcription factor E2F1 [KO:K17454]
100583853  E2F2; transcription factor E2F2 [KO:K09389]
100594018  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
100583326  TP53; cellular tumor antigen p53 [KO:K04451]
100599083  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
100593432  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
100583800  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
115830865  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
100593013  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
100588483  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
100605065  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
100598341  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
100581386  TGFB1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375]
100596183  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
100591391  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
100592854  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
100606849  TGFBR2; TGF-beta receptor type-2 isoform X2 [KO:K04388] [EC:2.7.11.30]
100589735  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
100583279  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
100599586  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
100601625  BRCA2; breast cancer type 2 susceptibility protein [KO:K08775]
100584720  RAD51; DNA repair protein RAD51 homolog 1 isoform X1 [KO:K04482]
Compound
C00416  Phosphatidate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
  Authors
Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJ
  Title
Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.
  Journal
Clin Cancer Res 19:549-59 (2013)
DOI:10.1158/1078-0432.CCR-12-0032
Related
pathway
nle04010  MAPK signaling pathway
nle04012  ErbB signaling pathway
nle04110  Cell cycle
nle04115  p53 signaling pathway
nle04151  PI3K-Akt signaling pathway
nle04210  Apoptosis
nle04350  TGF-beta signaling pathway
nle04370  VEGF signaling pathway
nle04630  JAK-STAT signaling pathway
KO pathway
ko05212   
LinkDB

DBGET integrated database retrieval system